Canada markets closed

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
360.43-7.75 (-2.10%)
At close: 04:00PM EDT
361.15 +0.72 (+0.20%)
After hours: 04:58PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 26.25B
Enterprise Value 25.96B
Trailing P/E 47.55
Forward P/E 47.17
PEG Ratio (5 yr expected) 6.38
Price/Sales (ttm)9.22
Price/Book (mrq)9.79
Enterprise Value/Revenue 8.86
Enterprise Value/EBITDA 31.77

Trading Information

Stock Price History

Beta (5Y Monthly) 1.02
52-Week Change 3-1.56%
S&P500 52-Week Change 322.36%
52 Week High 3415.73
52 Week Low 3310.42
50-Day Moving Average 3376.74
200-Day Moving Average 3371.23

Share Statistics

Avg Vol (3 month) 3545.3k
Avg Vol (10 day) 3492.88k
Shares Outstanding 572.84M
Implied Shares Outstanding 673.21M
Float 872.36M
% Held by Insiders 10.56%
% Held by Institutions 195.91%
Shares Short (Apr 15, 2024) 4975.86k
Short Ratio (Apr 15, 2024) 42.72
Short % of Float (Apr 15, 2024) 41.74%
Short % of Shares Outstanding (Apr 15, 2024) 41.33%
Shares Short (prior month Mar 15, 2024) 41.21M

Dividends & Splits

Forward Annual Dividend Rate 40.8
Forward Annual Dividend Yield 40.22%
Trailing Annual Dividend Rate 30.78
Trailing Annual Dividend Yield 30.21%
5 Year Average Dividend Yield 40.26
Payout Ratio 410.29%
Dividend Date 3May 01, 2024
Ex-Dividend Date 4Jul 31, 2024
Last Split Factor 22:1
Last Split Date 3Sept 27, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 19.42%
Operating Margin (ttm)18.06%

Management Effectiveness

Return on Assets (ttm)11.40%
Return on Equity (ttm)20.84%

Income Statement

Revenue (ttm)2.93B
Revenue Per Share (ttm)39.55
Quarterly Revenue Growth (yoy)-3.00%
Gross Profit (ttm)N/A
EBITDA 809.6M
Net Income Avi to Common (ttm)568.7M
Diluted EPS (ttm)7.57
Quarterly Earnings Growth (yoy)-17.60%

Balance Sheet

Total Cash (mrq)601.8M
Total Cash Per Share (mrq)8.26
Total Debt (mrq)306.6M
Total Debt/Equity (mrq)11.44%
Current Ratio (mrq)2.61
Book Value Per Share (mrq)36.72

Cash Flow Statement

Operating Cash Flow (ttm)756.6M
Levered Free Cash Flow (ttm)143.34M